'Super Breed' Of Medicinal Cannabis Developed By British Drug Firm
Updated: Wednesday, 08 Jun 2011, 8:38 AM EDT
Published : Wednesday, 08 Jun 2011, 6:55 AM EDT
LONDON - A British pharmaceutical company was working Wednesday to develop a new breed of cannabis-based products aimed at treating a range of conditions including diabetes, epilepsy and Crohn's disease.
GW Pharmaceuticals, which launched a cannabis-derived medicine for symptoms of multiple sclerosis last year, has cross-bred different types of the plant to produce a new strain that could treat a wide range of disorders.
The new varieties contain enhanced levels of therapeutic compounds, including an appetite suppressant
cannabinoid called THCV, which the company hopes will be used in the treatment of type 2 diabetes, obesity and other metabolic disorders.